Physician profile
Ronald D Agee
NPI 1407037955
$1,989.96
in general payments reported to CMS, 2019-2025
17 companies · $415 in 2025
The $415 reported for 2025 was more than what a typical Foot Surgery provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $218 · 2020: $38.11 · 2021: $145 · 2022: $181 · 2023: $492 · 2024: $501 · 2025: $415.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,409.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,408.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $645.46 | 2022-2025 | Nuzyra |
| Stryker Corporation | $366.52 | 2022-2025 | Ortholoc 2 Lapifuse, Asnis, Ortholoc 3di |
| Horizon Therapeutics Plc | $198.72 | 2019-2020 | |
| Organogenesis INC. | $177.71 | 2021-2023 | Puraply Antimicrobial |
| Kerecis Limited | $120.95 | 2023-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Ibsa Pharma INC. | $79.81 | 2023-2024 | Tirosint, Licart, Tirosint |
| Grt US Holding, INC. | $58.35 | 2020-2022 | |
| Ani Pharmaceuticals, INC. | $54.79 | 2025 | Purified Cortrophin Gel |
| Convatec INC. | $53.59 | 2023-2024 | |
| Vertex Pharmaceuticals Incorporated | $41.22 | 2025 | |
| Boston Scientific Corporation | $34.62 | 2024 | |
| Melinta Therapeutics, LLC | $34.33 | 2019 | |
| Smith+Nephew, INC. | $33.12 | 2022-2024 | Versajet |
| Depuy Synthes Sales INC. | $24.33 | 2022 | |
| Solventum Corporation | $23.71 | 2025 | Activ.A.C. |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $21.90 | 2022 | |
| Bioventus LLC | $20.83 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronald Agee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.